Xiaojing Jiao

483 total citations
24 papers, 367 citations indexed

About

Xiaojing Jiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Xiaojing Jiao has authored 24 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Biomedical Engineering. Recurrent topics in Xiaojing Jiao's work include Nanoplatforms for cancer theranostics (4 papers), Inflammasome and immune disorders (3 papers) and Graphene and Nanomaterials Applications (3 papers). Xiaojing Jiao is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Inflammasome and immune disorders (3 papers) and Graphene and Nanomaterials Applications (3 papers). Xiaojing Jiao collaborates with scholars based in China and France. Xiaojing Jiao's co-authors include Huijuan Zhang, Xiali Zhu, Zhenzhong Zhang, Lin Hou, Fengmin Shao, Qianqian Chen, Lei Yan, Huixia Cao, Hongling Zhang and Qianqian Chen and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Scientific Reports.

In The Last Decade

Xiaojing Jiao

20 papers receiving 361 citations

Peers

Xiaojing Jiao
Miaojuan Qiu China
Qingqing Huang China
May Lin Yap Australia
Binglin Ye China
Yuting Xiang China
Zhida Shen China
Chunrong Gu China
Keke Ding China
Lishan Tan China
Miaojuan Qiu China
Xiaojing Jiao
Citations per year, relative to Xiaojing Jiao Xiaojing Jiao (= 1×) peers Miaojuan Qiu

Countries citing papers authored by Xiaojing Jiao

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Jiao more than expected).

Fields of papers citing papers by Xiaojing Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Jiao. The network helps show where Xiaojing Jiao may publish in the future.

Co-authorship network of co-authors of Xiaojing Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Jiao. A scholar is included among the top collaborators of Xiaojing Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Jiao. Xiaojing Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Yandong, Lei Yan, Huixia Cao, Xiaojing Jiao, & Fengmin Shao. (2025). The Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic Nephropathy: Using Bioinformatics Analysis and Experimental Confirmation. Diabetes Metabolic Syndrome and Obesity. Volume 18. 1087–1098. 1 indexed citations
2.
Lin, Tao, Xiaoling Zhang, Xuegang Niu, et al.. (2025). Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study. Frontiers in Pharmacology. 16. 1642137–1642137.
3.
Zhang, Yuan, et al.. (2025). Edaravone ameliorates inflammation in ischemic stroke mouse by regulating the CYP1A1 pathway through gut microbiota. Experimental Neurology. 390. 115263–115263. 1 indexed citations
4.
5.
Niu, Xuegang, Hongwei Liu, Xiaojing Jiao, et al.. (2025). Sleep duration, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A prospective cohort study. Diabetes Research and Clinical Practice. 221. 112026–112026.
6.
7.
Zhang, Lina, Yanliang Wang, Jing Tan, et al.. (2024). Receptor-interacting protein kinase 1 confers autophagic promotion of gasdermin E-mediated pyroptosis in aristolochic acid-induced acute kidney injury. Ecotoxicology and Environmental Safety. 284. 116944–116944. 1 indexed citations
8.
Wang, Ning, Yifeng Hu, Shasha Wang, et al.. (2024). Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma. Scientific Reports. 14(1). 624–624. 3 indexed citations
9.
Gong, Juanni, Yuan Ding, Wei Wang, et al.. (2024). Insufficiency of quality of life as the treatment endpoint for balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension. Journal of Translational Internal Medicine. 12(2). 148–156. 3 indexed citations
10.
Liu, Xia, Xiaojing Jiao, Yang Li, et al.. (2023). Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study. International Journal of COPD. Volume 18. 907–917. 11 indexed citations
11.
Jiao, Xiaojing, Jiayu Liu, Wei Wang, et al.. (2023). Padua prediction score may be inappropriate for VTE risk assessment in hospitalized patients with acute respiratory conditions: A Chinese single-center cohort study. IJC Heart & Vasculature. 49. 101301–101301. 3 indexed citations
12.
Zhang, Lina, Xiaojing Jiao, Lu Liu, et al.. (2022). Autophagy promotes GSDME-mediated pyroptosis via intrinsic and extrinsic apoptotic pathways in cobalt chloride-induced hypoxia reoxygenation-acute kidney injury. Ecotoxicology and Environmental Safety. 242. 113881–113881. 35 indexed citations
13.
Yang, Zhong‐Nan, Lei Yan, Huixia Cao, et al.. (2021). Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis. The Journal of Immunology. 206(8). 1752–1764. 9 indexed citations
14.
Yan, Lei, et al.. (2021). Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 11. 603455–603455. 18 indexed citations
15.
Zheng, Yan, Yuan Ma, Huixia Cao, et al.. (2020). Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorganic Chemistry. 108. 104561–104561. 9 indexed citations
16.
Jiao, Xiaojing, Dong Zhang, Quan Hong, et al.. (2019). Netrin-1 works with UNC5B to regulate angiogenesis in diabetic kidney disease. Frontiers of Medicine. 14(3). 293–304. 18 indexed citations
17.
Zhang, Huijuan, Xiaojing Jiao, Qianqian Chen, et al.. (2016). A multi-functional nanoplatform for tumor synergistic phototherapy. Nanotechnology. 27(8). 85104–85104. 19 indexed citations
18.
Zhang, Huijuan, Qianqian Chen, Xiaojing Jiao, et al.. (2015). Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles. Journal of drug targeting. 23(6). 552–567. 30 indexed citations
19.
Zhang, Huijuan, et al.. (2014). Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy. Biomaterials. 37. 353–366. 88 indexed citations
20.
Zhang, Huijuan, Lin Hou, Xiaojing Jiao, et al.. (2014). In vitro and in vivo Evaluation of Antitumor Drug-Loaded Aptamer Targeted Single-Walled Carbon Nanotubes System. Current Pharmaceutical Biotechnology. 14(13). 1105–1117. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miaojuan Qiu Breakdown of academic impact, for papers by Qingqing Huang Breakdown of academic impact, for papers by May Lin Yap Breakdown of academic impact, for papers by Binglin Ye Breakdown of academic impact, for papers by Yuting Xiang Breakdown of academic impact, for papers by Zhida Shen Breakdown of academic impact, for papers by Chunrong Gu Breakdown of academic impact, for papers by Keke Ding Breakdown of academic impact, for papers by Lishan Tan
Rankless by CCL
2026